Metabolics Pharma
Philadelphia, US · Founded 2024 · Delaware corporation
Founders & leadership
RL
Richard LarsonExecutive
JD
John DessoukiNamed on SEC filing
Board
MK
Mark KampBoard director
MF
Mark FinnBoard director
BM
Barry MillerBoard director
JA
Jay A BrammerBoard director
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 1 round · 2024
▶$5.5MraisedSep 2024 · 7 investors · BiotechnologyRule 506(b)
▶$5.5MraisedSep 2024 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark KampDirector
- John DessoukiExecutive Officer, Director
- Mark FinnDirector
- Barry MillerDirector
- Jay A BrammerDirector
- Richard LarsonExecutive Officer, Director
- Offering amount
- $6.3M
- Amount sold
- $5.5M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Metabolics Pharma raised?
- Metabolics Pharma has disclosed $5.5M raised across 1 round.
- Where is Metabolics Pharma headquartered?
- Metabolics Pharma is headquartered in Philadelphia, US.